1V199

1V199 is a synthetic small molecule agonist of Toll-like receptor 7 (TLR7), designed as an NHS ester derivative of the TLR7 agonist 1V209, allowing it to covalently couple to primary amine groups on proteins under physiological conditions. It has been studied as an immunomodulatory agent for its ability to stimulate innate immunity, suppress tumor growth, and serve as a rapid-acting vaccine adjuvant by linking to antigens or bacterial components. In preclinical models, intratumoral administration of 1V199 inhibits tumor growth and improves survival in mice with melanoma, and in solution, coupling to antigens can rapidly induce immune responses, making it useful in experimental vaccine and cancer immunotherapy research.